Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
04-2019 | 04-2018 | 04-2017 | 04-2016 | 04-2015 | |
Cash Flows From Operating Activities | |||||
Net Income | 4,650,000 | 3,095,000 | 4,024,000 | 3,538,000 | 2,675,000 |
Depreciation Amortization | 2,659,000 | 2,644,000 | 2,917,000 | 2,849,000 | 1,382,000 |
Income taxes - deferred | -304,000 | -919,000 | -459,000 | -460,000 | -926,000 |
Accounts receivable | -581,000 | -275,000 | -75,000 | -435,000 | -413,000 |
Other Working Capital | -1,080,000 | -173,000 | 139,000 | -1,403,000 | 797,000 |
Other Operating Activity | 1,663,000 | 312,000 | 334,000 | 1,129,000 | 1,387,000 |
Operating Cash Flow | $7,007,000 | $4,684,000 | $6,880,000 | $5,218,000 | $4,902,000 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 2,151,000 | 1,027,000 | 985,000 | 4,518,000 | -1,692,000 |
PPE Investments | -1,134,000 | -1,068,000 | -1,254,000 | -1,046,000 | -571,000 |
Net Acquisitions | -1,827,000 | 5,921,000 | -1,324,000 | -1,213,000 | -14,884,000 |
Other Investing Activity | 36,000 | -22,000 | 22,000 | -14,000 | 89,000 |
Investing Cash Flow | $-774,000 | $5,858,000 | $-1,571,000 | $2,245,000 | $-17,058,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | -713,000 | -249,000 | 906,000 | 146,000 | 149,000 |
Debt Issued | 7,794,000 | 21,000 | 2,140,000 | 0 | 19,942,000 |
Debt Repayment | -7,948,000 | -7,370,000 | -863,000 | -5,132,000 | -1,268,000 |
Common Stock Issued | 992,000 | 403,000 | 428,000 | 491,000 | 649,000 |
Common Stock Repurchased | -2,877,000 | -2,171,000 | -3,544,000 | -2,830,000 | -1,920,000 |
Dividend Paid | -2,693,000 | -2,494,000 | -2,376,000 | -2,139,000 | -1,337,000 |
Other Financing Activity | 14,000 | -94,000 | 26,000 | -79,000 | -266,000 |
Financing Cash Flow | $-5,431,000 | $-11,954,000 | $-3,283,000 | $-9,543,000 | $15,949,000 |
Exchange Rate Effect | -78,000 | 114,000 | 65,000 | 113,000 | -353,000 |
Beginning Cash Position | 3,669,000 | 4,967,000 | 2,876,000 | 4,843,000 | 1,403,000 |
End Cash Position | 4,393,000 | 3,669,000 | 4,967,000 | 2,876,000 | 4,843,000 |
Net Cash Flow | $724,000 | $-1,298,000 | $2,091,000 | $-1,967,000 | $3,440,000 |
Free Cash Flow | |||||
Operating Cash Flow | 7,007,000 | 4,684,000 | 6,880,000 | 5,218,000 | 4,902,000 |
Capital Expenditure | -1,134,000 | -1,068,000 | -1,254,000 | -1,046,000 | -571,000 |
Free Cash Flow | 5,873,000 | 3,616,000 | 5,626,000 | 4,172,000 | 4,331,000 |